These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27562057)

  • 1. Dysregulation of redox pathways in liver fibrosis.
    Torok NJ
    Am J Physiol Gastrointest Liver Physiol; 2016 Oct; 311(4):G667-G674. PubMed ID: 27562057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of NADPH oxidases in the redox biology of liver fibrosis.
    Crosas-Molist E; Fabregat I
    Redox Biol; 2015 Dec; 6():106-111. PubMed ID: 26204504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
    Gong Y; Yang Y
    Life Sci; 2020 Sep; 256():117909. PubMed ID: 32512009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
    Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
    Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of oxidative stress and molecular changes in liver fibrosis: a review.
    Sánchez-Valle V; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
    Curr Med Chem; 2012; 19(28):4850-60. PubMed ID: 22709007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative and nitrosative stress and fibrogenic response.
    Urtasun R; Conde de la Rosa L; Nieto N
    Clin Liver Dis; 2008 Nov; 12(4):769-90, viii. PubMed ID: 18984466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NADPH oxidases in liver fibrosis.
    Paik YH; Kim J; Aoyama T; De Minicis S; Bataller R; Brenner DA
    Antioxid Redox Signal; 2014 Jun; 20(17):2854-72. PubMed ID: 24040957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation.
    Cai SM; Yang RQ; Li Y; Ning ZW; Zhang LL; Zhou GS; Luo W; Li DH; Chen Y; Pan MX; Li X
    Antioxid Redox Signal; 2016 May; 24(14):795-812. PubMed ID: 26728324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice.
    Mormone E; Lu Y; Ge X; Fiel MI; Nieto N
    Gastroenterology; 2012 Mar; 142(3):612-621.e5. PubMed ID: 22138190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.
    Foglia B; Cannito S; Bocca C; Parola M; Novo E
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro.
    Longato L; Andreola F; Davies SS; Roberts JL; Fusai G; Pinzani M; Moore K; Rombouts K
    Free Radic Biol Med; 2017 Jan; 102():162-173. PubMed ID: 27890721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β.
    Foo NP; Lin SH; Lee YH; Wu MJ; Wang YJ
    Toxicology; 2011 Mar; 282(1-2):39-46. PubMed ID: 21251946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
    Mallat A; Lotersztajn S
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Oxidative Stress for the Treatment of Liver Fibrosis.
    Luangmonkong T; Suriguga S; Mutsaers HAM; Groothuis GMM; Olinga P; Boersema M
    Rev Physiol Biochem Pharmacol; 2018; 175():71-102. PubMed ID: 29728869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of liver fibrosis: role of oxidative stress.
    Poli G
    Mol Aspects Med; 2000 Jun; 21(3):49-98. PubMed ID: 10978499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis.
    Yang JJ; Tao H; Huang C; Li J
    Food Chem Toxicol; 2013 Sep; 59():421-7. PubMed ID: 23793039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update.
    Elpek GÖ
    World J Gastroenterol; 2014 Jun; 20(23):7260-76. PubMed ID: 24966597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alisma Shugan Decoction (ASD) Ameliorates Hepatotoxicity and Associated Liver Dysfunction by Inhibiting Oxidative Stress and p65/Nrf2/JunD Signaling Dysregulation In Vivo.
    Sun Y; Pan H; Shen S; Xia Z; Yu Z; Li C; Sun P; Xin C
    Med Sci Monit; 2020 Jul; 26():e921738. PubMed ID: 32672153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astaxanthin inhibits the reduction of glycolysis during the activation of hepatic stellate cells.
    Bae M; Lee Y; Pham TX; Hu S; Park YK; Lee JY
    Life Sci; 2020 Sep; 256():117926. PubMed ID: 32535081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.